Experts Advancing Global Health

Hero Image
Photo of Erika G. Marques de Menezes, Ph.D.

Erika G. Marques de Menezes, Ph.D.

Engineered EVs for precision therapy

Dr. Marques de Menezes is an assistant investigator at Vitalant Research Institute (VRI), San Francisco, and an assistant professor in the Department of Laboratory Medicine at University of California, San Francisco (UCSF). She earned her Master’s and Ph.D. degrees in HIV pathogenesis from the Sao Paulo State University in Brazil and completed her post-doctoral work at VRI in extracellular vesicles (EVs) and HIV pathogenesis. 

In acknowledgment of Marques de Menezes’ vision and record of scientific innovation, she was the recipient of the 2023 Association for the Advancement of Blood and Biotherapies (AABB) Foundation Early Career Scientific Research Grant and also received the prestigious National Institutes of Health (NIH) Director’s Pioneer Catalyst Award (DP1) in 2024 for pursuing highly innovative and pioneering research on extracellular vesicles and HIV comorbidities.

Current Positions

Assistant Investigator, VRI 

Assistant Professor, UCSF Department of Laboratory Medicine

Links

Erika Marques de Menezes - LinkedIn 

Education & Training

B.S., Nutrition, Central Paulista University Center

M.S., Nutrition Sciences, Sao Paulo State University 

Ph.D., Nutrition Sciences, Sao Paulo State University 

Post Doctoral Research Fellow, Immunology, Extracellular Vesicles, HIV pathogenesis, VRI/UCSF

Publications

Publications in Google Scholar

Publications in NLM's PubMed

Research Interest

The Marques de Menezes lab is dedicated to developing innovative, integrated approaches in the emerging field of EVs to identify potential predictor biomarkers and elucidate new putative targets for pharmacologic therapies that may be broadly applicable for the treatment of inflammatory heart disease in HIV+ and non-HIV populations. A second interest of the laboratory is exploring novel approaches in transfusion medicine, with special emphasis on how EVs and their cargo within stored platelet products impact the immune system and vascular activity in transfusion recipients. Our long-term research goal is to develop engineered EVs to serve as novel therapeutic strategies to optimize health. 

Engineered EVs for Precision Therapy
Blood as a Source of Therapeutic Extracellular Vesicles
EVs as Versatile Signaling Mediators